Synapse - Works

Results (4073)

Breast cancer in the elderly: Is MRI helpful?

Meeting Abstract

Pilewskie, M.; Hirsch, A.; Eaton, A. A.; Stempel, M.; Morris, E.; Gemignani, M. L.
Cancer Research (2013)

Impact of adjuvant trastuzumab (T) with chemotherapy on breast cancer specific and cardiac outcomes in older women with small, node-negative HER2-positive breast cancer

Meeting Abstract

Cadoo, K. A.; Morris, P. G.; Patil, S.; Norton, L.; Hudis, C. A.; McArthur, H. L.
Cancer Research (2013)

Fulltext@MSK | Save

An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer

Meeting Abstract

Cadoo, K. A.; Morris, P. G.; Lake, D. E.; D'Andrea, G. M.; Dickler, M. N.; Gilewski, T. A.; Dang, C. T.; McArthur, H. L.; Bromberg, J. F.; Goldfarb, S. B.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer with cardiac biomarker data

Meeting Abstract

Iyengar, N. M.; Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g

Meeting Abstract

Krop, I. E.; Suter, T. M.; Dirix, L.; Romieu, G.; Zamagni, C.; Citron, M. L.; Campone, M.; Dang, C. T.; Xu, N.; Smitt, M.; more...
Cancer Research (2013)

Fulltext@MSK | Save

EGFR expression is associated with decreased response from HER2 targeted therapeutics in the neoadjuvant setting in the NeoALTTO trial

Meeting Abstract

Rimm, D. L.; Holmes, E.; Schalper, K.; Bradbury, I.; Zarrella, E.; Ellis, C.; Baselga, J.; Eidtmann, H.; Piccart, M.; Harbeck, N.; more...
Cancer Research (2013)

Fulltext@MSK | Save

A phase 2 single-arm study of the clinical activity and safety of enzalutamide in patients with advanced androgen receptor-positive triple-negative breast cancer

Meeting Abstract

Traina, T. A.; O'Shaughnessy, J.; Kelly, C.; Schwartzberg, L.; Gucalp, A.; Peterson, A.; Bhattacharya, S.; Trudeau, M.; Hudis, C. A.; Schmid, P.
Cancer Research (2013)

Fulltext@MSK | Save

Phase I study of ARN-810, a novel selective estrogen receptor degrader, in post-menopausal women with locally advanced or metastatic estrogen receptor positive breast cancer

Meeting Abstract

Mayer, I. A.; Bardia, A.; Dickler, M. N.; Manning, H. C.; Mahmood, U.; Ulaner, G. A.; Hager, J. H.; Rix, P.; Zack, N.; Maneval, E. C.; more...
Cancer Research (2013)

Fulltext@MSK | Save

A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors

Meeting Abstract

Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Heckman-Stoddard, B. M.; Dunn, B.; Garber, J. E.; Crew, K. D.; Hershman, D. L.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Validating the link between obesity and breast inflammation in women with breast cancer (BC)

Meeting Abstract

Iyengar, N. M.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Harbus, M. D.; Falcone, D. J.; Gucalp, A.; Morrow, M.; Hudis, C. A.; Dannenberg, A. J.
Cancer Research (2013)

Fulltext@MSK | Save